Suppr超能文献

盐酸雷尼替丁胃滞留给药系统:制剂与体外评价

Gastroretentive drug delivery system of ranitidine hydrochloride: formulation and in vitro evaluation.

作者信息

Dave Brijesh S, Amin Avani F, Patel Madhabhai M

机构信息

Shree S.K. Patel College of Pharmaceutical Education & Research, Ganpat Vidyanagar, India.

出版信息

AAPS PharmSciTech. 2004 Apr 8;5(2):e34. doi: 10.1208/pt050234.

Abstract

The purpose of this research was to prepare a gastroretentive drug delivery system of ranitidine hydrochloride. Guar gum, xanthan gum, and hydroxypropyl methylcellulose were evaluated for gel-forming properties. Sodium bicarbonate was incorporated as a gas-generating agent. The effects of citric acid and stearic acid on drug release profile and floating properties were investigated. The addition of stearic acid reduces the drug dissolution due to its hydrophobic nature. A 3(2) full factorial design was applied to systemically optimize the drug release profile. The amounts of citric acid anhydrous (X1) and stearic acid (X2) were selected as independent variables. The times required for 50% (t50) and 80% drug dissolution (t80), and the similarity factor f2 were selected as dependent variables. The results of the full factorial design indicated that a low amount of citric acid and a high amount of stearic acid favors sustained release of ranitidine hydrochloride from a gastroretentive formulation. A theoretical dissolution profile was generated using pharmacokinetic parameters of ranitidine hydrochloride. The similarity factor f2 was applied between the factorial design batches and the theoretical dissolution profile. No significant difference was observed between the desired release profile and batches F2, F3, F6, and F9. Batch F9 showed the highest f2 (f2 = 75) among all the batches, and this similarity is also reflected in t50 (approximately 214 minutes) and t80 (approximately 537 minutes) values. These studies indicate that the proper balance between a release rate enhancer and a release rate retardant can produce a drug dissolution profile similar to a theoretical dissolution profile.

摘要

本研究的目的是制备盐酸雷尼替丁胃滞留给药系统。对瓜尔胶、黄原胶和羟丙基甲基纤维素的凝胶形成特性进行了评估。加入碳酸氢钠作为产气剂。研究了柠檬酸和硬脂酸对药物释放曲线和漂浮性能的影响。由于硬脂酸的疏水性,其添加会降低药物的溶出度。采用3(2)全因子设计对药物释放曲线进行系统优化。选择无水柠檬酸(X1)和硬脂酸(X2)的用量作为自变量。选择50%(t50)和80%药物溶出所需时间(t80)以及相似因子f2作为因变量。全因子设计结果表明,低量柠檬酸和高量硬脂酸有利于盐酸雷尼替丁从胃滞留制剂中持续释放。利用盐酸雷尼替丁的药代动力学参数生成了理论溶出曲线。在因子设计批次和理论溶出曲线之间应用相似因子f2。在期望释放曲线与批次F2、F3、F6和F9之间未观察到显著差异。批次F9在所有批次中显示出最高的f2(f2 = 75),这种相似性也体现在t50(约214分钟)和t80(约537分钟)值上。这些研究表明,释放速率增强剂和释放速率阻滞剂之间的适当平衡可以产生与理论溶出曲线相似的药物溶出曲线。

相似文献

4
Statistical optimization of ranitidine HCl floating pulsatile delivery system for chronotherapy of nocturnal acid breakthrough.
Eur J Pharm Sci. 2009 Jun 28;37(3-4):363-9. doi: 10.1016/j.ejps.2009.03.006. Epub 2009 Mar 24.
5
Formulation and evaluation of floating tablet of H2-receptor antagonist.
Drug Dev Ind Pharm. 2015;41(9):1499-511. doi: 10.3109/03639045.2014.959969. Epub 2015 Jul 21.
6
8
Comparative bioavailability of two oral formulations of ranitidine.
Biopharm Drug Dispos. 2006 Jan;27(1):23-7. doi: 10.1002/bdd.477.
9
Leaky enteric coating on ranitidine hydrochloride beads: dissolution and prediction of plasma data.
Eur J Pharm Biopharm. 2008 Aug;69(3):977-85. doi: 10.1016/j.ejpb.2008.02.019. Epub 2008 Feb 29.

引用本文的文献

1
Evaluation of pharmacokinetic interactions of amoxicillin with ranitidine in healthy human volunteers of Karachi, Pakistan.
PLoS One. 2022 May 24;17(5):e0267791. doi: 10.1371/journal.pone.0267791. eCollection 2022.
2
Use of nanohybrid nanomaterials in water treatment: highly efficient removal of ranitidine.
RSC Adv. 2020 Oct 8;10(61):37050-37063. doi: 10.1039/d0ra05530a. eCollection 2020 Oct 7.
3
6
Risk-based approach for systematic development of gastroretentive drug delivery system.
Drug Deliv Transl Res. 2016 Oct;6(5):579-96. doi: 10.1007/s13346-016-0315-x.
7
Design and evaluation of polyox and pluronic controlled gastroretentive delivery of troxipide.
J Drug Deliv. 2014;2014:804616. doi: 10.1155/2014/804616. Epub 2014 Nov 19.
8
Novel swellable polymer of orchidaceae family for gastroretentive drug delivery of famotidine.
Drug Des Devel Ther. 2014 Sep 9;8:1315-29. doi: 10.2147/DDDT.S68517. eCollection 2014.
10
A novel in situ gel formulation of ranitidine for oral sustained delivery.
Biomol Ther (Seoul). 2014 Feb;22(2):161-5. doi: 10.4062/biomolther.2013.109.

本文引用的文献

2
Rate of release of medicaments from ointment bases containing drugs in suspension.
J Pharm Sci. 1961 Oct;50:874-5. doi: 10.1002/jps.2600501018.
3
Colonic metabolism of ranitidine: implications for its delivery and absorption.
Int J Pharm. 2001 Oct 4;227(1-2):157-65. doi: 10.1016/s0378-5173(01)00794-3.
4
Ranitidine HCl: tablet film coating acidity and discoloration.
Drug Dev Ind Pharm. 2000 Jun;26(6):693-4. doi: 10.1081/ddc-100101286.
5
Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention.
J Control Release. 2000 Feb 3;63(3):235-59. doi: 10.1016/s0168-3659(99)00204-7.
6
Floating dosage forms: an in vivo study demonstrating prolonged gastric retention.
J Control Release. 1998 Oct 30;55(1):3-12. doi: 10.1016/s0168-3659(97)00266-6.
9
Influence of shape factors on kinetics of drug release from matrix tablets. II. Experimental.
J Pharm Sci. 1974 May;63(5):732-7. doi: 10.1002/jps.2600630517.
10
Linearization of dissolution rate curves by the Weibull distribution.
J Pharm Pharmacol. 1972 Dec;24(12):979-81. doi: 10.1111/j.2042-7158.1972.tb08930.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验